Darlene Dobkowski, Managing Editor for CURE® magazine, has been with the team since October 2020 and has covered health care in other specialties before joining MJH Life Sciences. She graduated from Emerson College with a Master’s degree in print and multimedia journalism. In her free time, she enjoys buying stuff she doesn’t need from flea markets, taking her dog everywhere and scoffing at decaf.
Immunotherapy for Frontline Treatment of Kidney Cancer Has ‘Curative Potential’
November 3rd 2021An expert discusses how the kidney cancer treatment landscape has changed over the last few years, although the number of options available for patients may make it somewhat confusing to navigate.
Read More
Prior Authorizations for Oral Cancer Drugs May Delay Time Patients Receive Therapy
November 1st 2021When patients with cancer are faced with receiving a prior authorization from their insurance provider for oral anticancer drugs, it is important that they advocate for themselves, according to an expert.
Read More
Navigating the Ins and Outs of Implant Reconstruction After Breast Cancer Surgery
October 6th 2021Different breast implant options and potential complications may make the reconstruction process difficult to understand, but one expert discusses the importance of knowing what you want and hopefully avoiding postsurgical issues.
Read More
Keytruda-Lenvima Combo for Advanced Renal Cell Carcinoma Signifies ‘a Great Time for the Field’
August 20th 2021Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although patients should be monitored for side effects that can be easily managed.
Read More